{
  "id": 20381915,
  "title": "Lotte Biologics Wins First Major Commercial Production Deal for Songdo Plant 1",
  "url": "https://urgent.news/2026/11/17/lotte-biologics-wins-first-major-commercial-production-deal-for",
  "topic": "business",
  "section": "Business",
  "published": "2026-11-17T05:10:51.000Z",
  "source": {
    "name": "BusinessKorea",
    "slug": "businesskorea",
    "url": "https://www.businesskorea.co.kr/news/articleView.html?idxno=281497"
  },
  "original_language": "en",
  "account": null,
  "summary": "Lotte Biologics has secured its first major commercial production contract for Plant 1 at its Songdo Bio Campus in Incheon, positioning itself as a key player in the global contract development and manufacturing organization (CDMO) market. The company has signed a contract with a global pharmaceutical company for the production of key products, including active pharmaceutical ingredients (APIs) and finished drug products, with full-scale operations targeted for 2027. The undisclosed contract value and specific terms indicate the significance of this deal, as it provides a basis for the company to ramp up utilization as the facility begins operations.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}